Skip to main content
. 2019 Feb 13;11(2):214. doi: 10.3390/cancers11020214
Abbrev. Definition
ACC adenoid cystic carcinoma
AML acute myelocytic leukemia
Bcl-2 B-cell lymphoma 2
Btz bortezomib
CDK cyclin-dependent kinase
CML chronic myelogenous leukemia
CPT camptothecin
DAG diacylglycerol
DN dominant-negative
EGFR epidermal growth factor receptor
ERK extracellular signal-regulated kinase
GBM glioblastoma multiforme
HSC hematopoietic stem cells
IFN Interferon-α
IM imatinib mesylate
JNK c-Jun N-terminal kinase
LSC leukemia stem cells
MAPK mitogen-activated protein kinase
Mcl-1 myeloid cell leukemia 1
mTOR mechanistic target of rapamycin
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
NF-κB nuclear factor-κB
NHEK normal human epidermal keratinocytes
NHF normal human fibroblasts
NHK normal human keratinocytes
ODN oligonucleotide
PKC protein kinase C
SASP senescence-associated secretory phenotype
SRF Sorafenib
TNF tumor necrosis factor-α
TGase 1 transglutaminase 1
TPA 12-O-tetradecanoylphorbol-13-acetate
TRAIL TNF-related apoptosis-inducing ligand
WT wild-type